Marshall Wace
BIOA icon

Marshall Wace’s BioAge Labs BIOA Stock Holding History

Marshall Wace’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-31,743
Closed -$778K – 3764
2026
Q2 		$778K Sell
31,743
-158,729
-83% -$2.87M ﹤0.01% 2324
2026
Q1 		$3.33M Sell
190,472
-32,476
-15% -$625K ﹤0.01% 1515
2025
Q4 		$2.95M Buy
222,948
+48,752
+28% +$432K ﹤0.01% 1397
2025
Q3 		$1.02M Sell
174,196
-52,593
-23% -$246K ﹤0.01% 1932
2025
Q2 		$937K Buy
226,789
+173,388
+325% +$699K ﹤0.01% 1884
2025
Q1 		$201K Buy
+53,401
New +$247K ﹤0.01% 2405
2024
Q4 		– Sell
-200,000
Closed -$4.16M – 3082
2024
Q3 		$4.16M Buy
+200,000
New +$4.01M 0.01% 1066

Other funds holding BIOA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor San Francisco, California $252M AUM 45.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
CM
Cosmic Management West Hollywood, California $327M AUM 21.97% 1-Year Est. Return

Marshall Wace's BIOA Position: Q3 2026 in Review

Marshall Wace sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 31,743 shares — an estimated $778K sold.

Marshall Wace first reported a position in BIOA in Q3 2024 and held it in 7 quarters. The position peaked at $4.16M in Q3 2024. 104 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Marshall Wace reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
  • Marshall Wace sold 31,743 BioAge Labs shares in Q3 2026, an estimated $778K.
  • Marshall Wace first reported a position in BioAge Labs in Q3 2024 and held it in 7 quarters.
  • Marshall Wace's BioAge Labs position peaked at $4.16M in Q3 2024.
  • 104 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.